keyword
https://read.qxmd.com/read/38373820/respiratory-symptoms-exacerbations-and-sleep-disturbances-are-more-common-among-participants-with-asthma-and-chronic-airflow-limitation-an-epidemiological-study-in-estonia-iceland-and-sweden
#21
JOURNAL ARTICLE
Stephanie Mindus, Thorarinn Gislason, Bryndis Benediktsdottir, Rain Jogi, Robert Moverare, Andrei Malinovschi, Christer Janson
BACKGROUND: Chronic airflow limitation (CAL) is a hallmark of chronic obstructive pulmonary disease but is also present in some patients with asthma. We investigated respiratory symptoms, sleep and health status of participants with and without CAL with particular emphasis on concurrent asthma using data from adult populations in Iceland, Estonia and Sweden investigated within the Burden of Obstructive Lung Disease study. METHODS: All participants underwent spirometry with measurements of forced expiratory volume in 1 s (FEV1 ) and forced vital capacity (FVC) before and after bronchodilation...
February 19, 2024: BMJ Open Respiratory Research
https://read.qxmd.com/read/38371642/eosinophilic-oesophagitis-in-a-nigerian-adolescent-a-case-report
#22
Ikobah Joanah Moses, Ikwuagwu Elekwachi, Ita Ukpabio, Theophilus Ugbem, Omeodu Chimankpan Okechukwu, Emmanuel Ekanem
Eosinophilic oesophagitis (EoE) is a chronic immune and antigen-mediated disease characterized by symptoms related to oesophageal dysfunction, and histologically, is marked by eosinophilic infiltrate in the oesophageal mucosa. It is prevalent in developed countries and considered rare in developing countries. There is an interplay of allergic and genetic factors in the aetiology of EoE. This is a report of EoE in a 15-year-old female adolescent in Nigeria who presented to the University of Calabar Teaching Hospital with recurrent vomiting, abdominal pain, weight loss, and dysphagia...
2024: Pan African Medical Journal
https://read.qxmd.com/read/38356205/wake-up-to-gastro-oesophageal-reflux-disease-the-interplay-between-arousal-and-night-time-reflux
#23
REVIEW
Hanan Elkalawy, Wael Abosena, Mohamed Elnagger, Harmony Allison
This review examines the temporal association between nocturnal gastro-oesophageal reflux and sleep-arousal cycles. Most nocturnal gastro-oesophageal reflux events occur during the awake cycle, and arousals precede most nocturnal gastro-oesophageal reflux events, indicating that arousal from sleep predisposes to nocturnal gastro-oesophageal reflux. This sheds light on the complex relationship between nocturnal gastro-oesophageal reflux and sleep, and has implications for managing nocturnal gastro-oesophageal reflux symptoms...
February 14, 2024: Journal of Sleep Research
https://read.qxmd.com/read/38350716/clinicopathological-characterisation-of-mtap-alterations-in-gastrointestinal-cancers
#24
JOURNAL ARTICLE
Gianluca Mauri, Giorgio Patelli, Laura Roazzi, Emanuele Valtorta, Alessio Amatu, Giovanna Marrapese, Erica Bonazzina, Federica Tosi, Katia Bencardino, Gabriele Ciarlo, Elisa Mariella, Silvia Marsoni, Alberto Bardelli, Emanuela Bonoldi, Andrea Sartore-Bianchi, Salvatore Siena
BACKGROUND: Methylthioadenosine phosphorylase (MTAP) is an essential metabolic enzyme in the purine and methionine salvage pathway. In cancer, MTAP gene copy number loss ( MTAP loss) confers a selective dependency on the related protein arginine methyltransferase 5. The impact of MTAP alterations in gastrointestinal (GI) cancers remains unknown although hypothetically druggable. Here, we aim to investigate the prevalence, clinicopathological features and prognosis of MTAP loss GI cancers...
February 13, 2024: Journal of Clinical Pathology
https://read.qxmd.com/read/38341203/fruquintinib-plus-oxaliplatin-combined-with-s-1-sox-as-neoadjuvant-therapy-for-locally-advanced-gastric-cancer-gc-or-gastro-oesophageal-junction-adenocarcinoma-gej-a-multicentre-phase-ii-single-arm-open-label-clinical-trial-frutineoga-protocol
#25
JOURNAL ARTICLE
Liucheng Wu, Haiqing Yan, Yuzhou Qin, Mingwei Huang, Tingan Wang, Qinwen Jin, Weiyuan Wei
INTRODUCTION: Curing locally advanced gastric cancer (GC) or gastro-oesophageal junction adenocarcinoma (GEJ) with surgery alone is challenging. Neoadjuvant chemotherapy (NCT) has become the standard treatment for patients with locally advanced GC/GEJ, and SOX is the most common neoadjuvant regimen in China. The generally good tolerability in patients and fruquintinib's low potential for drug-drug interaction suggest that it may be highly suitable for combinations with other antineoplastic therapies...
February 10, 2024: BMJ Open
https://read.qxmd.com/read/38313139/long-term-effect-of-sleeve-gastrectomy-vs-roux-en-y-gastric-bypass-in-people-living-with-severe-obesity-a-phase-iii-multicentre-randomised-controlled-trial-sleevebypass
#26
JOURNAL ARTICLE
L Ulas Biter, Judith Wh 't Hart, Bo J Noordman, J Frans Smulders, Simon Nienhuijs, Martin Dunkelgrün, Johannes F Zengerink, Erwin Birnie, Irene Am Friskes, Guido Hh Mannaerts, Jan A Apers
BACKGROUND: Sleeve gastrectomy is the most performed metabolic surgical procedure worldwide. However, conflicting results offer no clear evidence about its long-term clinical comparability to Roux-en-Y gastric bypass. This study aims to determine their equivalent long-term weight loss effects. METHODS: This randomised open-label controlled trial was conducted from 2012 until 2017 in two Dutch bariatric hospitals with a 5-year follow-up (last follow-up July 29th, 2022)...
March 2024: The Lancet regional health. Europe
https://read.qxmd.com/read/38222857/budget-impact-of-refluxstop%C3%A2-as-a-treatment-for-patients-with-refractory-gastro-oesophageal-reflux-disease-in-the-united-kingdom
#27
JOURNAL ARTICLE
Sam Harper, Lukasz Grodzicki, Stuart Mealing, Elizabeth Gemmill, Paul Goldsmith, Ahmed Ahmed
Background: Gastro-oesophageal reflux disease (GORD) is a common condition associated with heartburn and regurgitation. Standard of care for GORD patients in the UK involves initial treatment with proton pump inhibitors (PPIs) and laparoscopic antireflux surgery in patients unwilling to continue or intolerant of long-term PPI treatment. Recently, RefluxStop™, a novel, implantable medical device, has proven to be an efficacious and cost-effective treatment for patients with GORD. The current analysis aimed to describe the budget impact of introducing RefluxStop™ within National Health Service (NHS) England and Wales...
2024: Journal of health economics and outcomes research
https://read.qxmd.com/read/38221552/mucosal-neuroimmune-mechanisms-in-gastro-oesophageal-reflux-disease-gord-pathogenesis
#28
REVIEW
Tom Leech, Madusha Peiris
Gastro-oesophageal reflux disease (GORD) is a chronic condition characterised by visceral pain in the distal oesophagus. The current first-line treatment for GORD is proton pump inhibitors (PPIs), however, PPIs are ineffective in a large cohort of patients and long-term use may have adverse effects. Emerging evidence suggests that nerve fibre number and location are likely to play interrelated roles in nociception in the oesophagus of GORD patients. Simultaneously, alterations in cells of the oesophageal mucosa, namely epithelial cells, mast cells, dendritic cells, and T lymphocytes, have been a focus of GORD research for several years...
March 2024: Journal of Gastroenterology
https://read.qxmd.com/read/38177402/pathophysiology-of-gastro-oesophageal-reflux-disease-implications-for-diagnosis-and-management
#29
REVIEW
Julieta Argüero, Daniel Sifrim
Gastro-oesophageal reflux disease (GERD) is a common gastrointestinal disorder in which retrograde flow of gastric content into the oesophagus causes uncomfortable symptoms and/or complications. It has a multifactorial and partially understood pathophysiology. GERD starts in the stomach, where the refluxate material is produced. Following the trajectory of reflux, the failure of the antireflux barrier, primarily the lower oesophageal sphincter and the crural diaphragm, enables the refluxate to reach the oesophageal lumen, triggering oesophageal or extra-oesophageal symptoms...
April 2024: Nature Reviews. Gastroenterology & Hepatology
https://read.qxmd.com/read/38171474/expression-of-epidermal-growth-factor-receptor-egfr-in-systemic-sclerosis-patients-ssc-and-gastro-oesophageal-reflux-disease-gord
#30
JOURNAL ARTICLE
Andrea Pasta, Francesco Calabrese, Shirin Djahandideh Sheijani, Manuele Furnari, Edoardo G Giannini, Federica Grillo, Elisa Marabotto, Luca Mastracci, Giuseppe Murdaca, Simone Negrini, Edoardo Vincenzo Savarino, Vincenzo Savarino, Patrizia Zentilin
INTRODUCTION: Systemic sclerosis (SSc) affects the connective tissue and leads to an abnormal fibrotic process in the skin and internal organs. Epidermal Growth Factor Receptor (EGFR) is able to induce cell proliferation and differentiation, and its expression is increased in SSc patients with pulmonary artery hypertension and in skin biopsies in patients with scleroderma. To date, no data on esophageal expression of EGFR are available in SSc patients. We aimed to evaluate whether the pro-fibrogenic pathways of SSc may affect EGFR expression in the esophagus...
February 2024: Immunology Letters
https://read.qxmd.com/read/38135304/developing-an-electronic-health-record-measure-of-low-value-esophagogastroduodenoscopy-for-gerd-at-a-large-academic-health-system
#31
JOURNAL ARTICLE
Courtney A Reynolds, Vishnu Nair, Chad Villaflores, Katherine Dominguez, Julia Cave Arbanas, Madeline Treasure, Samuel Skootsky, Chi-Hong Tseng, Catherine Sarkisian, Arpan Patel, Kevin Ghassemi, A Mark Fendrick, Folasade P May, John N Mafi
OBJECTIVES: Low-value esophagogastroduodenoscopies (EGDs) for uncomplicated gastro-oesophageal reflux disease (GERD) can harm patients and raise patient and payer costs. We developed an electronic health record (EHR) 'eMeasure' to detect low-value EGDs. DESIGN: Retrospective cohort of 518 adult patients diagnosed with GERD who underwent initial EGD between 1 January 2019 and 31 December 2019. SETTING: Outpatient primary care and gastroenterology clinics at a large, urban, academic health centre...
December 22, 2023: BMJ Open Quality
https://read.qxmd.com/read/38134948/neoadjuvant-and-adjuvant-pembrolizumab-plus-chemotherapy-in-locally-advanced-gastric-or-gastro-oesophageal-cancer-keynote-585-an-interim-analysis-of-the-multicentre-double-blind-randomised-phase-3-study
#32
JOURNAL ARTICLE
Kohei Shitara, Sun Young Rha, Lucjan S Wyrwicz, Takashi Oshima, Nina Karaseva, Mikhail Osipov, Hisateru Yasui, Hiroshi Yabusaki, Sergey Afanasyev, Young-Kyu Park, Salah-Eddin Al-Batran, Takaki Yoshikawa, Patricio Yanez, Maria Dib Bartolomeo, Sara Lonardi, Josep Tabernero, Eric Van Cutsem, Yelena Y Janjigian, Do-Youn Oh, Jianming Xu, Xiao Fang, Chie-Schin Shih, Pooja Bhagia, Yung-Jue Bang
BACKGROUND: The benefit of combination neoadjuvant and adjuvant chemotherapy and immune checkpoint inhibition in patients with locally advanced, resectable gastric or gastro-oesophageal adenocarcinoma is unknown. We assess the antitumor activity of neoadjuvant and adjuvant pembrolizumab plus chemotherapy in patients with locally advanced resectable gastric or gastro-oesophageal adenocarcinoma. METHODS: The KEYNOTE-585 study is a multicentre, randomised, placebo-controlled, double-blind, phase 3 study done at 143 medical centres in 24 countries...
December 19, 2023: Lancet Oncology
https://read.qxmd.com/read/38128953/gastro-oesophageal-reflux-and-idiopathic-pulmonary-fibrosis-sorting-the-chicken-and-the-egg-by-genetic-link
#33
EDITORIAL
Chad A Newton, Imre Noth, Ganesh Raghu
No abstract text is available yet for this article.
December 2023: European Respiratory Journal
https://read.qxmd.com/read/38124342/factors-associated-with-decision-regret-after-bariatric-surgery
#34
JOURNAL ARTICLE
Phillip J Dijkhorst, Leontien M G Nijland, Ruben N van Veen, Steve M M de Castro
It is assumed that the individuals who undergo bariatric surgery will experience significant improvements in their health and overall well-being. However, it is yet to be examined whether these individuals may also experience subsequent decision regret. The level of regret regarding the choice to undergo bariatric surgery was assessed 1 year after bariatric surgery using the Decision Regret Scale (DRS). Associations of regret with patient characteristics, complications, weight loss and quality of life (BODY-Q) were investigated using linear regression analyses...
April 2024: Clinical Obesity
https://read.qxmd.com/read/38104575/efficacy-and-safety-of-the-muscarinic-receptor-agonist-karxt-xanomeline-trospium-in-schizophrenia-emergent-2-in-the-usa-results-from-a-randomised-double-blind-placebo-controlled-flexible-dose-phase-3-trial
#35
RANDOMIZED CONTROLLED TRIAL
Inder Kaul, Sharon Sawchak, Christoph U Correll, Rishi Kakar, Alan Breier, Haiyuan Zhu, Andrew C Miller, Steven M Paul, Stephen K Brannan
BACKGROUND: New treatments with new mechanisms are urgently needed for people with schizophrenia. Xanomeline is a dual M1 and M4 -preferring muscarinic receptor agonist that does not block D2 dopamine receptors, unlike all currently approved treatments for schizophrenia. Xanomeline-trospium (KarXT) combines xanomeline with the peripherally restricted muscarinic receptor antagonist trospium chloride with the goal of ameliorating xanomeline-related adverse events associated with peripheral muscarinic receptors...
January 13, 2024: Lancet
https://read.qxmd.com/read/38103903/eosinophilic-enteritis-in-a-case-of-cystic-fibrosis-an-elusive-diagnosis-with-an-elementary-cure
#36
JOURNAL ARTICLE
Gomathy Aarthy Nageswaran, Viveksandeep Thoguluva Chandrasekar, Intisar Ghleilib, John Erikson Yap
A late adolescent man diagnosed with cystic fibrosis and presenting with predominantly gastrointestinal symptoms, including chronic constipation, exocrine pancreatic insufficiency and gastro-oesophageal reflux disease, experienced recurrent episodes of nausea, vomiting and abdominal pain. CT of the abdomen unveiled the presence of chronic appendicitis, alongside constipation without evidence of distal intestinal obstruction syndrome. Endoscopic biopsies revealed small bowel eosinophilic infiltrates. Subsequently, the patient underwent an appendectomy, and a tailored regimen was established to address constipation, resulting in an initial alleviation of his symptoms...
December 16, 2023: BMJ Case Reports
https://read.qxmd.com/read/38074212/severe-hyponatraemia-peripartum-associated-with-omeprazole-therapy
#37
Adam Morton
Hyponatraemia is the most commonly encountered electrolyte abnormality in pregnancy and may be associated with adverse maternal and neonatal outcomes. Rapid onset, severe hyponatraemia has been reported with proton-pump inhibitor therapy in non-pregnant individuals. Gastro-oesophageal reflux is very common during pregnancy, and proton-pump inhibitors are available without a prescription in many countries. A case of severe maternal hyponatraemia in the setting of recent omeprazole therapy is presented. Health professionals should be aware of this complication given the availability of proton-pump inhibitors without prescription and high rates of gestational gastro-oesophageal reflux...
December 2023: Obstetric Medicine
https://read.qxmd.com/read/38050085/10-year-follow-up-results-of-the-european-achalasia-trial-a-multicentre-randomised-controlled-trial-comparing-pneumatic-dilation-with-laparoscopic-heller-myotomy
#38
RANDOMIZED CONTROLLED TRIAL
Guy Boeckxstaens, Stefanie Elsen, Ann Belmans, Vito Annese, Albert J Bredenoord, Olivier R Busch, Mario Costantini, Uberto Fumagalli, André J P M Smout, Jan Tack, Tim Vanuytsel, Giovanni Zaninotto, Renato Salvador
OBJECTIVE: As achalasia is a chronic disorder, long-term follow-up data comparing different treatments are essential to select optimal clinical management. Here, we report on the 10-year follow-up of the European Achalasia Trial comparing endoscopic pneumodilation (PD) with laparoscopic Heller myotomy (LHM). DESIGN: A total of 201 newly diagnosed patients with achalasia were randomised to either a series of PDs (n=96) or LHM (n=105). Patients completed symptom (Eckardt score) and quality-of-life questionnaires, underwent functional tests and upper endoscopy...
March 7, 2024: Gut
https://read.qxmd.com/read/37969407/minimally-invasive-surgery-for-gastro-oesophageal-junction-adenocarcinoma-current-evidence-and-future-perspectives
#39
REVIEW
Rodica Bîrlă, Petre Hoara, Florin Achim, Valeriu Dinca, Diana Ciuc, Silviu Constantinoiu, Adrian Constantin
Minimally invasive surgery is increasingly indicated in the management of malignant disease. Although oesophagectomy is a difficult operation, with a long learning curve, there is actually a shift towards the laparoscopic/thoracoscopic/ robotic approach, due to the advantages of visualization, surgeon comfort (robotic surgery) and the possibility of the whole team to see the operation as well as and the operating surgeon. Although currently there are still many controversial topics, about the surgical treatment of patients with gastro-oesophageal junction (GOJ) adenocarcinoma, such as the type of open or minimally invasive surgical approach, the type of oesophago-gastric resection, the type of lymph node dissection and others, the minimally invasive approach has proven to be a way to reduce postoperative complications of resection, especially by decreasing pulmonary complications...
October 15, 2023: World Journal of Gastrointestinal Oncology
https://read.qxmd.com/read/37966015/improvement-in-severe-asthma-patients-receiving-biologics-and-factors-associated-with-persistent-insufficient-control-a-real-life-national-study
#40
JOURNAL ARTICLE
Laurent Guilleminault, Claire Camus, Chantal Raherison-Semjen, Audrey Capdepon, Arnaud Bourdin, Philippe Bonniaud, Stéphanie Fry, Gilles Devouassoux, François-Xavier Blanc, Christophe Pison, Clairelyne Dupin, Naji Khayath, Joelle Courdeau, Judith Valcke-Brossollet, Cécilia Nocent-Ejnaini, Fabien Rolland, Carmen Lamandi, Alain Proust, Anaig Ozier, Laurent Portel, Wanda Gaspard, Pauline Roux-Claude, Antoine Beurnier, Stéphanie Martinez, Jean-Marc Dot, Florence Hennegrave, Guillaume Vignal, Etienne Auvray, Nicolas Paleiron, Nicolas Just, Jean Miltgen, Maud Russier, Cécile Olivier, Camille Taillé, Alain Didier
BACKGROUND: Biological therapies have revolutionized the treatment of severe asthma with type 2 inflammation. Although such treatments are very effective in reducing exacerbation and the dose of oral steroids, little is known about the persistence of symptoms in severe asthma patients treated with biologics. PURPOSE: We aim to describe asthma control and healthcare consumption of severe asthma patients treated with biologics. DESIGN: The Second Souffle study is a real-life prospective observational study endorsed by the Clinical Research Initiative in Severe Asthma: a Lever for Innovation & Science Network...
2023: Therapeutic Advances in Respiratory Disease
keyword
keyword
163896
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.